b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31103845</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>14</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1879-1379</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>115</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>08</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of psychiatric research</Title>\n                <ISOAbbreviation>J Psychiatr Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Anxiety disorders in childhood are associated with youth IL-6 levels: A mediation study including metabolic stress and childhood traumatic events.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>43-50</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0022-3956(19)30234-1</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychires.2019.05.011</ELocationID>\n            <Abstract>\n                <AbstractText>Anxiety disorders (ADs) are chronic conditions that often have their onset in childhood and adolescence. Inflammation and oxidative stress markers have been associated with the vulnerability to ADs, however it is not known if ADs in childhood can influence these biomarkers levels longitudinally. This study aims to investigate a possible association between ADs and serum levels of IL-10, IL-6, IL-1\xce\xb2, TNF-\xce\xb1, BDNF, and protein carbonyl content, assessed after 5 years of follow-up. Moreover, we studied possible mediators for these associations, including physical activity, metabolic markers and childhood trauma. From 240 individuals evaluated at baseline, 73 were re-evaluated in the follow-up. Psychiatric diagnoses were assessed with the K-SADS or the MINI and child trauma questionnaire (CTQ) to evaluate presence of trauma. We searched serum levels of IL-10, IL-6, IL-1\xce\xb2 and TNF-\xce\xb1 (flow cytometry), BDNF (sandwich-ELISA) and carbonyl content in proteins (PCC method). We found a significant direct association between ADs at baseline and log IL-6 (B\xe2\x80\xaf=\xe2\x80\xaf0.34, S.E.\xe2\x80\xaf=\xe2\x80\xaf0.11, p\xe2\x80\xaf=\xe2\x80\xaf0.002) and between AD and log BDNF (B\xe2\x80\xaf=\xe2\x80\xaf-0.10, S.E.\xe2\x80\xaf=\xe2\x80\xaf0.05, p\xe2\x80\xaf=\xe2\x80\xaf0.033) five years later. Searching for possible mediators of these association, we found that levels of HDL-cholesterol (\xce\x94B\xe2\x80\xaf=\xe2\x80\xaf-0.148) partially mediated the association between ADs and IL-6. No significant mediators were found in the association between ADs and BDNF. Moreover, this association is no longer significant after controlling for the presence of depression. Our results demonstrated that previous AD diagnosis was associated with higher levels of IL-6 in the follow-up evaluation, suggesting that the presence of anxiety in childhood could influence altered inflammatory markers.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>de Baumont</LastName>\n                    <ForeName>Angelica</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Anxiety Disorders Outpatient Program for Children and Adolescents, Protaia, Federal University of Rio Grande do Sul, UFRGS/Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil; Post Graduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Basic Research and Advanced Investigations in Neurosciences, BRAIN Laboratory, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bortoluzzi</LastName>\n                    <ForeName>Andressa</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Anxiety Disorders Outpatient Program for Children and Adolescents, Protaia, Federal University of Rio Grande do Sul, UFRGS/Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil; Post Graduate Program in Neuroscience, Institute of Basic Sciences/Health, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Basic Research and Advanced Investigations in Neurosciences, BRAIN Laboratory, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wollenhaupt de Aguiar</LastName>\n                    <ForeName>Bianca</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Molecular Psychiatry, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil; St. Joseph\'s Healthcare Hamilton, Department of Psychiatry &amp; Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Scotton</LastName>\n                    <ForeName>Ellen</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Post Graduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Laboratory of Molecular Psychiatry, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pinto Guimar\xc3\xa3es</LastName>\n                    <ForeName>Luciano Santos</ForeName>\n                    <Initials>LS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit of Epidemiology and Biostatistics, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kapczinski</LastName>\n                    <ForeName>Flavio</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Post Graduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Laboratory of Molecular Psychiatry, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Belem da Silva</LastName>\n                    <ForeName>Cristiano Tschiedel</ForeName>\n                    <Initials>CT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Medicine, Universidade do Vale do Rio dos Sinos (Unisinos), S\xc3\xa3o Leopoldo, RS, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Manfro</LastName>\n                    <ForeName>Gisele Gus</ForeName>\n                    <Initials>GG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Anxiety Disorders Outpatient Program for Children and Adolescents, Protaia, Federal University of Rio Grande do Sul, UFRGS/Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil; Post Graduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Post Graduate Program in Neuroscience, Institute of Basic Sciences/Health, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil; Basic Research and Advanced Investigations in Neurosciences, BRAIN Laboratory, Hospital de Cl\xc3\xadnicas de Porto Alegre, HCPA, Porto Alegre, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil. Electronic address: gmanfro@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>10</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Psychiatr Res</MedlineTA>\n            <NlmUniqueID>0376331</NlmUniqueID>\n            <ISSNLinking>0022-3956</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Anxiety disorder</Keyword>\n            <Keyword MajorTopicYN="Y">BDNF</Keyword>\n            <Keyword MajorTopicYN="Y">Cytokines</Keyword>\n            <Keyword MajorTopicYN="Y">HDL-Cholesterol</Keyword>\n            <Keyword MajorTopicYN="Y">IL-6</Keyword>\n            <Keyword MajorTopicYN="Y">Inflammation</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31103845</ArticleId>\n            <ArticleId IdType="pii">S0022-3956(19)30234-1</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jpsychires.2019.05.011</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'